{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:43Z","timestamp":1787995063324,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to evaluate the safety and efficacy of innovative retinoic acid (RA) eluting stents with bioabsorbable polymer. Sixty stents divided in ten groups were implanted in the iliac arteries of 30 rabbits. Two polymers (\u201cA\u201d, poly (lactic-co-glycolic acid) and \u201cB\u201d, polylactic acid), and three doses (\u201cLow\u201d, \u201cMedium\u201d and \u201cHigh\u201d) of RA (groups: AL, AM, AH, BL, BM, BH) were used on cobalt chromium stents (Rontis Corporation), one group of bare stent (C), one group (D) of Everolimus eluting stent (Xience-Pro, Abbot Vascular), and two groups of Rontis Everolimus eluting stents coated with polymer A (EA) and B (EB). Treated arteries were explanted after 4\u00a0weeks, processed by methyl methacrylate resin and evaluated by histopathology. None of the implanted stents was related with thrombus formation or extensive inflammation. Image analysis showed limited differences between groups regarding area stenosis (BH, D and EB groups had the lower values). Group BH had lower intimal mean thickness than AH (105.1 vs 75.3\u00a0\u03bcm, p\u2009=\u20090.024). Stents eluting RA, a non-cytotoxic drug, were not related with thrombus formation and had an acceptable degree of stenosis 4\u00a0weeks post implantation. RA dose and type of polymer may play role in the biocompatibility of the stents.<\/jats:p>","DOI":"10.1038\/s41598-022-16025-5","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:02:49Z","timestamp":1659524569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Histopathological evaluation of a retinoic acid eluting stent in a rabbit iliac artery model"],"prefix":"10.1038","volume":"12","author":[{"given":"Ioanna","family":"Samara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Katsouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen","family":"Semertzioglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios","family":"Vratimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia I.","family":"Moula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos A.","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Theofanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triantafyllia","family":"Papadimitropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Bouratzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Karanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Fotiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lampros K.","family":"Michalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anargyros N.","family":"Moulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"16025_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"F-J Neumann","year":"2019","unstructured":"Neumann, F.-J. et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur. Heart J. 40, 87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394 (2019).","journal-title":"Eur. Heart J."},{"key":"16025_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2125.2006.02840.x","volume":"64","author":"R Moreno","year":"2007","unstructured":"Moreno, R. et al. Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation. Br. J. Clin. Pharmacol. 64, 110\u2013112. https:\/\/doi.org\/10.1111\/j.1365-2125.2006.02840.x (2007).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"16025_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/14779072.2018.1435274","volume":"16","author":"P McKavanagh","year":"2018","unstructured":"McKavanagh, P., Zawadowski, G., Ahmed, N. & Kutryk, M. The evolution of coronary stents. Exp. Rev. Cardiovasc. Ther. 16, 219\u2013228. https:\/\/doi.org\/10.1080\/14779072.2018.1435274 (2018).","journal-title":"Exp. Rev. Cardiovasc. Ther."},{"key":"16025_CR4","doi-asserted-by":"publisher","first-page":"E1150","DOI":"10.21037\/jtd.2016.10.93","volume":"8","author":"D Buccheri","year":"2016","unstructured":"Buccheri, D., Piraino, D., Andolina, G. & Cortese, B. Understanding and managing in-stent restenosis: A review of clinical data, from pathogenesis to treatment. J. Thorac. Dis. 8, E1150\u2013E1162. https:\/\/doi.org\/10.21037\/jtd.2016.10.93 (2016).","journal-title":"J. Thorac. Dis."},{"key":"16025_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev.nutr.24.012003.132407","volume":"24","author":"DR Soprano","year":"2004","unstructured":"Soprano, D. R., Qin, P. & Soprano, K. J. Retinoic acid receptors and cancers. Annu. Rev. Nutr. 24, 201\u2013221. https:\/\/doi.org\/10.1146\/annurev.nutr.24.012003.132407 (2004).","journal-title":"Annu. Rev. Nutr."},{"key":"16025_CR6","doi-asserted-by":"publisher","unstructured":"Hunsu, V. O., Facey, C. O. B., Fields, J. Z. & Boman, B. M. Retinoids as chemo-preventive and molecular-targeted anti-cancer therapies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22147731 (2021).","DOI":"10.3390\/ijms22147731"},{"key":"16025_CR7","doi-asserted-by":"publisher","unstructured":"Sugawara, A. Effects of retinoids on vasculatures. J. Endocrinol. Thyroid Res. https:\/\/doi.org\/10.19080\/jetr.2017.02.555587 (2017).","DOI":"10.19080\/jetr.2017.02.555587"},{"key":"16025_CR8","doi-asserted-by":"publisher","first-page":"13856","DOI":"10.1038\/s41598-021-93459-3","volume":"11","author":"E Suganuma","year":"2021","unstructured":"Suganuma, E., Sato, S., Honda, S. & Nakazawa, A. All trans retinoic acid alleviates coronary stenosis by regulating smooth muscle cell function in a mouse model of Kawasaki disease. Sci. Rep. 11, 13856. https:\/\/doi.org\/10.1038\/s41598-021-93459-3 (2021).","journal-title":"Sci. Rep."},{"key":"16025_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10557-020-07089-4","volume":"35","author":"Y Yu","year":"2021","unstructured":"Yu, Y. et al. All-trans retinoic acid prevented vein grafts stenosis by inhibiting Rb-E2F mediated cell cycle progression and KLF5-RARalpha interaction in human vein smooth muscle cells. Cardiovasc. Drugs Ther. 35, 103\u2013111. https:\/\/doi.org\/10.1007\/s10557-020-07089-4 (2021).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"16025_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jconrel.2018.01.020","volume":"274","author":"EK Gregory","year":"2018","unstructured":"Gregory, E. K. et al. Inhibiting intimal hyperplasia in prosthetic vascular grafts via immobilized all-trans retinoic acid. J. Control Release 274, 69\u201380. https:\/\/doi.org\/10.1016\/j.jconrel.2018.01.020 (2018).","journal-title":"J. Control Release"},{"key":"16025_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/s0008-6363(02)00709-5","volume":"57","author":"C Herdeg","year":"2003","unstructured":"Herdeg, C. et al. Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery. Cardiovasc. Res. 57, 544\u2013553. https:\/\/doi.org\/10.1016\/s0008-6363(02)00709-5 (2003).","journal-title":"Cardiovasc. Res."},{"key":"16025_CR12","doi-asserted-by":"publisher","unstructured":"Carazo, A. et al. Vitamin A update: forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity. Nutrients. https:\/\/doi.org\/10.3390\/nu13051703 (2021).","DOI":"10.3390\/nu13051703"},{"key":"16025_CR13","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.bbalip.2011.07.001","volume":"230\u2013240","author":"EJ Rhee","year":"1821","unstructured":"Rhee, E. J., Nallamshetty, S. & Plutzky, J. Retinoid metabolism and its effects on the vasculature. Biochim. Biophys. Acta 230\u2013240, 2012. https:\/\/doi.org\/10.1016\/j.bbalip.2011.07.001 (1821).","journal-title":"Biochim. Biophys. Acta"},{"key":"16025_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s0008-6363(00)00312-6","volume":"49","author":"DI Axel","year":"2001","unstructured":"Axel, D. I. et al. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc. Res. 49, 851\u2013862. https:\/\/doi.org\/10.1016\/s0008-6363(00)00312-6 (2001).","journal-title":"Cardiovasc. Res."},{"key":"16025_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fphar.2019.00485","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. All-trans-retinoic acid suppresses neointimal hyperplasia and inhibits vascular smooth muscle cell proliferation and migration via activation of AMPK signaling pathway. Front. Pharmacol. 10, 485. https:\/\/doi.org\/10.3389\/fphar.2019.00485 (2019).","journal-title":"Front. Pharmacol."},{"key":"16025_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/jsre.2000.5887","volume":"90","author":"CD Leville","year":"2000","unstructured":"Leville, C. D. et al. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo. J. Surg. Res. 90, 183\u2013190. https:\/\/doi.org\/10.1006\/jsre.2000.5887 (2000).","journal-title":"J. Surg. Res."},{"key":"16025_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1067\/msy.2000.107371","volume":"128","author":"CD Leville","year":"2000","unstructured":"Leville, C. D. et al. All-trans-retinoic acid decreases cell proliferation and increases apoptosis in an animal model of vein bypass grafting. Surgery 128, 178\u2013184. https:\/\/doi.org\/10.1067\/msy.2000.107371 (2000).","journal-title":"Surgery"},{"key":"16025_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1161\/01.cir.98.12.1219","volume":"98","author":"JM Miano","year":"1998","unstructured":"Miano, J. M. et al. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation 98, 1219\u20131227. https:\/\/doi.org\/10.1161\/01.cir.98.12.1219 (1998).","journal-title":"Circulation"},{"key":"16025_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s0967-2109(99)00041-1","volume":"7","author":"JJ DeRose Jr","year":"1999","unstructured":"DeRose, J. J. Jr. et al. Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc. Surg. 7, 633\u2013639. https:\/\/doi.org\/10.1016\/s0967-2109(99)00041-1 (1999).","journal-title":"Cardiovasc. Surg."},{"key":"16025_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/01.atv.20.1.89","volume":"20","author":"PJ Wiegman","year":"2000","unstructured":"Wiegman, P. J. et al. All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit\u202f: A favorable effect on vessel remodeling. Arterioscler. Thromb. Vasc. Biol. 20, 89\u201395. https:\/\/doi.org\/10.1161\/01.atv.20.1.89 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"16025_CR21","doi-asserted-by":"publisher","first-page":"H1419","DOI":"10.1152\/ajpheart.00914.2013","volume":"307","author":"EK Gregory","year":"2014","unstructured":"Gregory, E. K. et al. Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats. Am. J. Physiol. Heart Circ. Physiol. 307, H1419-1429. https:\/\/doi.org\/10.1152\/ajpheart.00914.2013 (2014).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"16025_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCINTERVENTIONS.108.789974","volume":"1","author":"RS Schwartz","year":"2008","unstructured":"Schwartz, R. S. et al. Drug-eluting stents in preclinical studies: Updated consensus recommendations for preclinical evaluation. Circ. Cardiovasc. Interv. 1, 143\u2013153. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.108.789974 (2008).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"16025_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","volume":"17","author":"S Torii","year":"2020","unstructured":"Torii, S. et al. Drug-eluting coronary stents: Insights from preclinical and pathology studies. Nat. Rev. Cardiol. 17, 37\u201351. https:\/\/doi.org\/10.1038\/s41569-019-0234-x (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"16025_CR24","doi-asserted-by":"publisher","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18, e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","DOI":"10.1371\/journal.pbio.3000410"},{"key":"16025_CR25","unstructured":"European_Union. Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes. https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:en:PDF (2010)."},{"key":"16025_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/0300985809352978","volume":"47","author":"LE Perkins","year":"2010","unstructured":"Perkins, L. E. Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems. Vet. Pathol. 47, 58\u201376. https:\/\/doi.org\/10.1177\/0300985809352978 (2010).","journal-title":"Vet. Pathol."},{"key":"16025_CR27","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1097\/01.rvi.0000244836.16098.b1","volume":"17","author":"D Karnabatidis","year":"2006","unstructured":"Karnabatidis, D., Katsanos, K., Diamantopoulos, A., Kagadis, G. C. & Siablis, D. Transauricular arterial or venous access for cardiovascular experimental protocols in animals. J. Vasc. Interv. Radiol. 17, 1803\u20131811. https:\/\/doi.org\/10.1097\/01.rvi.0000244836.16098.b1 (2006).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"16025_CR28","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1109\/EMBC46164.2021.9630612","volume":"4324\u20134328","author":"C Kokkinos","year":"2021","unstructured":"Kokkinos, C. et al. FEA of drug-eluting stents and sensitivity analysis of a continuum damage model for the degradation of PLGA coating. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 4324\u20134328, 2021. https:\/\/doi.org\/10.1109\/EMBC46164.2021.9630612 (2021).","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16025-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:38:07Z","timestamp":1669354687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16025-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16025"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16025-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Anargyros Moulas and his lab acknowledge receiving research support from Rontis SA. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13305"}}